semaglutide patent expiration us 2031

semaglutide patent expiration us 2031 New Delhi, March 19, 2026 – On Friday, the key on semaglutide—the active molecule in Novo Nordisk's blockbuster drugs Ozempic and Wegovy— expired in India, marking a Semaglutide Patent Expiry: What Biosimilars

Name: semaglutide patent expiration us 2031 New Delhi, March 19, 2026 – On Friday, the key on semaglutide—the active molecule in Novo Nordisk's blockbuster drugs Ozempic and Wegovy— expired in India, marking a Semaglutide Patent Expiry: What Biosimilars
Brand: museeartisanaletruralclion.fr
SKU: 79245599686
Price: 29.06 USD
Availability: InStock
Rating: 4.4734 (28 reviews)

SKU: 79245599686

4.5

USD29.06 USD54.06

Pay in 4 interest-free payments of $7.26 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 25 - Aug 30

Description

Branded Ozempic contains proprietary stabilizers that Novo Nordisk developed specifically to extend room temperature stability to 56 days

GLP-1 Analogues (e.g., Liraglutide) : GLP-1 analogues, while not technically peptides, are medications based on the natural hormone glucagon-like peptide-1 (GLP-1)